Skip to main content
Delfa

← All assets

Lecozotan

7 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.

Trials

7

Ongoing

0

Recruiting

0

Completed

7

Sites

95

Countries

12

Endpoints

11

Composite endpoints

0

Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 11 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.

Development

Where the program stands

Trials by phase

Phase 1
4
Phase 2
2
Phase 2/3
1

Trials by status

Completed
7

Evidence coverage

What this asset has been measured on

Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.

Safety / tolerability / PK
5
Other (unclassified)
5
Global cognition
1

Most-measured metrics

Top 20 metrics across this asset's endpoints

Normalized metric codes are available for 1 of 11 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.

ADAS-CogCognition

1

Trials

Trials for this asset

Every trial for this asset, with the same search, filters, and sort as the Trials tab.

7 of 7

Alzheimer’s disease and related dementias trials
Asset / Disease areaKey I/E criterionEvidence
NCT00277810Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Lecozotan

Alzheimer’s disease

Alzheimer's diseasePh 2/3Completed83Jun 2008-
NCT00151398Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Donepezil, Lecozotan

Alzheimer’s disease

Alzheimer's diseasePh 2Completed56Mar 2008-
NCT00151333Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Lecozotan

Alzheimer’s disease

Alzheimer's diseasePh 2Completed3Apr 2005-
NCT00499642Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Lecozotan

Alzheimer’s disease

Age 18-55Ph 1Completed2Aug 2007-
NCT00494962Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Lecozotan

Alzheimer’s disease

Healthy volunteersPh 1Completed1Jun 2007-
NCT00366483Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

Lecozotan

Alzheimer’s disease

Age ≥18Ph 1Completed1--
NCT00563732Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

Lecozotan

Alzheimer’s disease

Age 18-55Ph 1Completed0Sep 2008-

Showing 1-7 of 7 trials